Chief Technology Officer and Vice President
Dr. Gary Liversidge is Chief Technology Officer and Vice
President, Research and Development for Alkermes, Inc. From 1981 to
1983, he completed a postdoctoral fellowship in Pharmaceutical
Chemistry at the University of Kansas with Dr. Takeru Higuchi. He
then joined the faculty at the School of Pharmacy of the University
of North Carolina, where he remained through 1985.
Since then he has held various positions in the Pharmaceutical
industry. Dr. Liversidge is the inventor of NanoCrystal®
technology. His inventions are incorporated into six licensed
products that help almost 2 million patients in the USA every day.
He holds 22 US patents and over 80 patent applications and has
authored over 50 publications and several monographs and book
He received his B. Pharm. from the University of Bradford,
England in 1978, and a Ph.D. in 1981 from the University of
Nottingham, England with Dr. David Grant.